title: Effect of ovarian hormones on genes promoting dendritic spines in laser-captured serotonin neurons from macaques.
abstract: Dendritic spines are the elementary structural units of neuronal plasticity and the cascades that promote dendritic spine remodeling center on Rho GTPases and downstream effectors of actin dynamics. In a model of hormone replacement therapy, we sought the effect of estradiol (E) and progesterone (P) on gene expression in these cascades in laser-captured serotonin neurons from rhesus macaques with complementary DNA array analysis. Ovariectomized rhesus macaques were treated with either placebo, E or E+P through Silastic implant for 1 month before euthanasia. The midbrain was obtained, sectioned and immunostained for tryptophan hydroxylase (TPH). TPH-positive neurons were laser captured using an Arcturus Laser Dissection Microscope (PixCell II). RNA from laser-captured serotonin neurons (n=2 animals/treatment) was hybridized to Rhesus Affymetrix GeneChips. With E±P treatment, there was a significant change in 744 probe sets (analysis of variance, P<0.05), but 10,493 probe sets exhibited a twofold or greater change. Pivotal changes in pathways leading to dendritic spine proliferation and transformation included twofold or greater increases in expression of the Rho GTPases called CDC42, Rac1 and RhoA. In addition, twofold or greater increases occurred in downstream effectors of actin dynamics, including p21-activated kinase (PAK1), Rho-associated coiled-coil-containing protein kinase (ROCK), PIP5K, IRSp53, Wiskott-Aldrich syndrome protein (WASP), WASP family Verprolin-homologous protein (WAVE), MLC, cofilin, gelsolin, profilin and three subunits of actin-related protein (ARP2/3). Finally, twofold or greater decreases occurred in CRIPAK, LIMK2 and myosin light chain kinase (MLCK). The regulation of RhoA, Rac1, CDC42, ROCK, PIP5k, IRSp53, WASP, WAVE, LIMK2, CRIPAK1, MLCK, ARP2/3 subunit 3, gelsolin, profilin and cofilin was confirmed with nested quantitative reverse transcriptase-PCR on laser-captured RNA (n=3 animals/treatment). The data indicate that ovarian steroids target gene expression of the Rho GTPases and pivotal downstream proteins, that in turn would promote dendritic spine proliferation and stabilization on serotonin neurons of the dorsal raphe nucleus.
authors.affiliation: Division of Reproductive Sciences, Oregon National Primate Research Center, Beaverton, OR97006, USA. betheac@ohsu.edu
authors.forename: C L
authors.initials: CL
authors.lastname: Bethea
authors.forename: A P
authors.initials: AP
authors.lastname: Reddy
mesh_terms: D000818:Animals; D049229:Dendritic Spines / Q000187:drug effects / Q000502:physiology*; D004343:Drug Implants; D004958:Estradiol / Q000494:pharmacology / Q000502:physiology*; D005260:Female; D007834:Lasers; D008253:Macaca mulatta; D042282:Microdissection / Q000295:instrumentation; D009419:Nerve Tissue Proteins / Q000235:genetics; D009473:Neuronal Plasticity / Q000187:drug effects / Q000502:physiology; D009474:Neurons / Q000502:physiology / Q000648:ultrastructure; D020411:Oligonucleotide Array Sequence Analysis; D010052:Ovariectomy; D010053:Ovary / Q000502:physiology*; D016133:Polymerase Chain Reaction; D011374:Progesterone / Q000494:pharmacology / Q000502:physiology*; D011903:Raphe Nuclei / Q000166:cytology / Q000502:physiology; D012701:Serotonin / Q000502:physiology*
chemical_list: D004343:Drug Implants; D009419:Nerve Tissue Proteins; D012701:Serotonin; D011374:Progesterone; D004958:Estradiol
references.citation: Hippocampus. 2000;10(5):555-60
references.pmid: 11075825
references.citation: J Neurochem. 2008 May;105(4):1129-43
references.pmid: 18182058
references.citation: J Cell Sci. 2001 Nov;114(Pt 21):3795-803
references.pmid: 11719546
references.citation: Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11412-7
references.pmid: 9736750
references.citation: Front Neuroendocrinol. 2002 Jan;23(1):41-100
references.pmid: 11906203
references.citation: Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14650-5
references.pmid: 18801922
references.citation: Brain Res Mol Brain Res. 2001 Jul 13;91(1-2):14-22
references.pmid: 11457488
references.citation: Nat Neurosci. 2000 Sep;3(9):887-94
references.pmid: 10966619
references.citation: Neuroscience. 2008 Jun 23;154(2):720-31
references.pmid: 18486349
references.citation: J Comp Neurol. 2003 Oct 27;465(4):540-50
references.pmid: 12975814
references.citation: Neuroendocrinology. 1993 Jan;57(1):1-6
references.pmid: 8479605
references.citation: J Cell Sci. 2002 Jan 15;115(Pt 2):239-40
references.pmid: 11839775
references.citation: J Neurosci. 2006 Mar 1;26(9):2571-8
references.pmid: 16510735
references.citation: J Neurosci. 1997 Mar 1;17(5):1848-59
references.pmid: 9030643
references.citation: Biol Psychiatry. 2003 Apr 15;53(8):707-42
references.pmid: 12706957
references.citation: Prog Neurobiol. 2005 Feb;75(3):161-205
references.pmid: 15882774
references.citation: Mol Psychiatry. 2003 Mar;8(3):353-60
references.pmid: 12660809
references.citation: Neuron. 2008 May 22;58(4):584-98
references.pmid: 18498739
references.citation: Nat Neurosci. 1999 Jan;2(1):44-9
references.pmid: 10195179
references.citation: J Neurobiol. 2005 Jul;64(1):34-46
references.pmid: 15884004
references.citation: Exp Neurol. 2004 Aug;188(2):351-64
references.pmid: 15246835
references.citation: Curr Biol. 2005 May 10;15(9):R346-57
references.pmid: 15886095
references.citation: Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1482-7
references.pmid: 9037079
references.citation: Dev Neurosci. 1998;20(2-3):253-62
references.pmid: 9691199
references.citation: Neuropsychopharmacology. 2002 Jul;27(1):12-24
references.pmid: 12062903
references.citation: Neuroendocrinology. 1994 Jul;60(1):50-61
references.pmid: 8090282
references.citation: J Neurosci. 2007 Jul 11;27(28):7408-17
references.pmid: 17626201